Cargando…
Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports
BACKGROUND: The advent of well-tolerated and effective anti-retroviral drugs against human immunodeficiency virus-1 (HIV-1) infection has been a major step forward that has achieved long-term survival in recent years. The number of HIV-1 infected patients who experience difficulty in swallowing tabl...
Autores principales: | Suzuki, Takefumi, Hara, Nobuko, Osa, Morichika, Misawa, Kazuhisa, Imai, Kazuo, Fujikura, Yuji, Maeda, Takuya, Sonehara, Wataru, Kawana, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606108/ https://www.ncbi.nlm.nih.gov/pubmed/28944075 http://dx.doi.org/10.1186/s40780-017-0093-8 |
Ejemplares similares
-
Chagas disease: a report of 17 suspected cases in Japan, 2012–2017
por: Imai, Kazuo, et al.
Publicado: (2019) -
Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection
por: Mehta, Rashmi, et al.
Publicado: (2018) -
Cerebral Syphilitic Gumma in Immunocompetent Man, Japan
por: Kodama, Tatsuya, et al.
Publicado: (2018) -
2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen
por: Ward, Douglas, et al.
Publicado: (2019) -
The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
por: Mehta, Rashmi, et al.
Publicado: (2020)